0001209191-23-037906.txt : 20230616
0001209191-23-037906.hdr.sgml : 20230616
20230616163019
ACCESSION NUMBER: 0001209191-23-037906
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230614
FILED AS OF DATE: 20230616
DATE AS OF CHANGE: 20230616
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Curnutte John T
CENTRAL INDEX KEY: 0001574589
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38722
FILM NUMBER: 231021640
MAIL ADDRESS:
STREET 1: PORTOLA PHARMACEUTICALS, INC.
STREET 2: 270 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Orchard Therapeutics plc
CENTRAL INDEX KEY: 0001748907
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 245 HAMMERSMITH ROAD, 3RD FLOOR
CITY: LONDON
STATE: X0
ZIP: W6 8PW
BUSINESS PHONE: 011-44-0-203-3846700
MAIL ADDRESS:
STREET 1: 245 HAMMERSMITH ROAD, 3RD FLOOR
CITY: LONDON
STATE: X0
ZIP: W6 8PW
FORMER COMPANY:
FORMER CONFORMED NAME: Orchard Rx Ltd
DATE OF NAME CHANGE: 20180802
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-14
0
0001748907
Orchard Therapeutics plc
ORTX
0001574589
Curnutte John T
C/O ORCHARD THERAPEUTICS PLC
245 HAMMERSMITH ROAD
LONDON
X0
W6 8PW
UNITED KINGDOM
1
0
0
0
0
Stock Option (Right to Buy)
0.495
2023-06-14
4
A
0
105000
0.00
A
2033-06-13
Ordinary Shares
105000
105000
D
All of the shares subject to this option vest upon the earlier to occur of June 14, 2024 or the date of the 2024 Annual General Meeting of the Company.
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents ten Ordinary Shares.
/s/ Frank Thomas, as attorney-in-fact
2023-06-16